pH-sensitive controlled release in vitro and pharmacokinetics of ibuprofen from hybrid nanocomposite using amine-modified bimodal mesopores silica as core and poly(methylacrylic acid) as shell
Source abstract
Abstract
Ibuprofen was encapsulated into pH-sensitive hybrid nanocomposite using amine-modified bimodal mesopores silica (BMMs) as core and poly(methylacrylic acid) (PMAA) as the shell. The various characterizations showed that PMAA-coated shell played a pH-dependent “open–close” switch, and BMMs as a stored drug carrier. The high drug loading and pH-responsive release performances in vitro could be successfully monitored by SAXS techniques, demonstrating the evolution of mass fractal with surface roughness and structural irregularities. The release mechanism was proposed, showing a “diffusion-controlled” profile in both acidic and alkaline medium. Finally, the pharmacokinetics of released-IBU in mice through intravenous injection was preliminarily explored.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · Polymer Surface Interaction Studies · Advanced Polymer Synthesis and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Beijing Key Laboratory for Green Catalysis and Separation, Department of Chemistry and Chemical Engineering, Beijing University of Technology, Beijing, China;
Department of Pharmaceutical Chemistry and Analysis, School of Pharmacy, The Fourth Military Medical University, Xi’an, Shaanxi Province, China
References (49)
Show source-provided references
1. 10.1021/cm001155910.1021/cm0011559 ↗
2. 10.1002/cphc.20050029410.1002/cphc.200500294 ↗
3. 10.1039/c1cc16004d10.1039/c1cc16004d ↗
4. 10.1016/j.ejps.2005.06.00910.1016/j.ejps.2005.06.009 ↗
5. 10.1016/j.matchemphys.2012.05.05910.1016/j.matchemphys.2012.05.059 ↗
6. 10.1039/C1JM13811A10.1039/C1JM13811A ↗
7. 10.1021/ja201779d10.1021/ja201779d ↗
8. 10.1016/j.addr.2010.03.01110.1016/j.addr.2010.03.011 ↗
9. 10.1016/j.jconrel.2011.12.01210.1016/j.jconrel.2011.12.012 ↗
10. 10.1016/j.biomaterials.2012.02.05910.1016/j.biomaterials.2012.02.059 ↗
11. 10.1021/la301643610.1021/la3016436 ↗
12. 10.1016/j.jconrel.2004.10.02510.1016/j.jconrel.2004.10.025 ↗
13. 10.1039/c3tb20758g10.1039/c3tb20758g ↗
14. 10.1021/ma971565r10.1021/ma971565r ↗
15. 10.1021/acsami.5b0598410.1021/acsami.5b05984 ↗
16. 10.1016/j.colsurfb.2018.05.02610.1016/j.colsurfb.2018.05.026 ↗
17. 10.1021/acsanm.8b0030710.1021/acsanm.8b00307 ↗
18. 10.1021/la801057910.1021/la8010579 ↗
19. 10.1021/jp904397810.1021/jp9043978 ↗
20. 10.1021/la102952n10.1021/la102952n ↗
21. 10.1016/j.biomaterials.2014.05.05110.1016/j.biomaterials.2014.05.051 ↗
22. 10.1016/j.materresbull.2014.01.03910.1016/j.materresbull.2014.01.039 ↗
23. 10.1177/088532821665328710.1177/0885328216653287 ↗
24. 10.1002/(SICI)1099–0488(19991115)37:22<3172::AID–POLB2>3.3.CO;2–I10.1002/(SICI)1099–0488(19991115)37:22<3172::AID–POLB2>3.3.CO;2–I ↗
25. 10.1002/jps.2466810.1002/jps.24668 ↗
26. 10.1021/la035115610.1021/la0351156 ↗
27. 10.1039/b707626f10.1039/b707626f ↗
28. 10.1016/j.ijpharm.2005.10.01310.1016/j.ijpharm.2005.10.013 ↗
29. 10.1016/j.polymer.2009.05.03310.1016/j.polymer.2009.05.033 ↗
30. 10.1016/j.matlet.2012.02.10210.1016/j.matlet.2012.02.102 ↗
31. 10.1016/j.polymer.2014.10.02710.1016/j.polymer.2014.10.027 ↗
32. 10.1080/10601325.2012.67176010.1080/10601325.2012.671760 ↗
33. 10.1016/j.carbpol.2006.03.01310.1016/j.carbpol.2006.03.013 ↗
34. 10.1002/app.4040310.1002/app.40403 ↗
35. 10.1016/j.colsurfb.2014.10.01310.1016/j.colsurfb.2014.10.013 ↗
36. 10.1016/j.micromeso.2003.12.01210.1016/j.micromeso.2003.12.012 ↗
37. 10.1021/cm040149010.1021/cm0401490 ↗
38. 10.1021/ja206998x10.1021/ja206998x ↗
39. 10.1016/j.cej.2007.07.07810.1016/j.cej.2007.07.078 ↗
40. 10.1016/j.micromeso.2017.05.00310.1016/j.micromeso.2017.05.003 ↗
41. 10.1021/jp051588510.1021/jp0515885 ↗
42. 10.1016/j.actbio.2012.06.00310.1016/j.actbio.2012.06.003 ↗
43. 10.1016/S0142-9612(00)00178-210.1016/S0142-9612(00)00178-2 ↗
44. 10.1021/cr940351u10.1021/cr940351u ↗
45. 10.1016/j.colsurfa.2012.03.01710.1016/j.colsurfa.2012.03.017 ↗
46. 10.1016/j.ejpb.2012.11.01910.1016/j.ejpb.2012.11.019 ↗
47. 10.1016/j.actbio.2012.09.01910.1016/j.actbio.2012.09.019 ↗
48. 10.1016/j.micromeso.2015.02.00810.1016/j.micromeso.2015.02.008 ↗
49. Teorell T. · Arch. Int Pharmacodyn. Ther · 1973 · 57 · 205